UnitedHealth Group Incorporated (UNH) is currently trading at $376.59. Based on 25 Wall Street analysts, the average target price is $481.72, implying a 27.9% upside. The consensus recommendation is BUY.

No firm-level price target raises or cuts for UNH are recorded in the past 30 days. Over the past 90 days, the feed records 17 target raises and 0 target cuts for UNH.

UNH

UnitedHealth Group Incorporated

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$376.59

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$380.00$529.00
Current $376.59
Median: $480.00Mean: $475.35Current: $376.59

Recent price target updates (latest 80)

  • JP MorganJul 21, 2026

    PT action: Raises

    $466.00 → $516.00

  • MizuhoJul 21, 2026

    PT action: Raises

    $470.00 → $493.00

  • BarclaysJul 20, 2026

    PT action: Raises

    $429.00 → $441.00

  • Morgan StanleyJul 17, 2026

    PT action: Raises

    $468.00 → $529.00

  • KeybancJul 17, 2026

    PT action: Raises

    $475.00 → $500.00

  • OppenheimerJul 17, 2026

    PT action: Raises

    $420.00 → $500.00

  • Truist SecuritiesJul 17, 2026

    PT action: Raises

    $480.00 → $500.00

  • RBC CapitalJul 17, 2026

    PT action: Raises

    $463.00 → $478.00

  • UBSJul 17, 2026

    PT action: Raises

    $460.00 → $490.00

  • BairdJul 16, 2026

    PT action: Raises

    $287.00 → $453.00

  • TD CowenJul 14, 2026

    PT action: Raises

    $337.00 → $430.00

  • Truist SecuritiesJul 14, 2026

    PT action: Raises

    $440.00 → $480.00

  • KeybancJul 14, 2026

    PT action: Raises

    $400.00 → $475.00

  • Wells FargoJul 13, 2026

    PT action: Raises

    $397.00 → $485.00

  • RBC CapitalJul 9, 2026

    PT action: Raises

    $400.00 → $463.00

  • HSBCJul 6, 2026

    PT action: Raises

    $300.00 → $380.00

  • Morgan StanleyJun 30, 2026

    PT action: Raises

    $453.00 → $468.00

  • B of A SecuritiesJun 24, 2026

    PT action: Raises

    $450.00 → $475.00

  • Leerink PartnersJun 17, 2026

    PT action: Raises

    $400.00 → $462.00

  • MizuhoJun 8, 2026

    PT action: Raises

    $440.00 → $460.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$481.72

Based on 25 analysts

Analyst Recommendations

Buy (22)Hold (4)Sell (0)

Upside

+27.92%

Market Cap

$338.03B

Financial & Investment Metrics

Next Earnings Date
Oct 13, 2026D-17
P/E Ratio (TTM)24.22
Forward P/E16.66
P/B Ratio3.46
Dividend Yield2.46%
Return on Equity (ROE)14.15%
Operating Margin7.13%
Debt to Equity69.21
Beta (Volatility)0.62
52 Week Range$255.97 - $461.62
LowCurrent: $376.59High

Daily editorial mentioning UNH

Price target moves

Citigroup Reshuffles Materials as FDX Sees Mixed Target Adjustments

The latest round of Wall Street revisions, as of June 25, 2026, highlights a distinct divergence in sentiment within the Materials sector. While Citigroup analysts have been busy adjusting their outlooks, the activity reflects a broader, more surgical approach to valuation that has spilled over into Industrials and Healthcare.

Who moved targets

Citigroup led the charge with a flurry of activity in the Materials space. They raised price targets on SHW to 380 from 355, alongside upward adjustments for PPG (114 to 125), LIN (585 to 600), and ECL (325 to 330). However, the firm simultaneously took a more cautious stance on other industry constituents, slashing targets for IFF, LYB, DOW, and CE. The most significant of these downward revisions was Celanese (CE), which saw its target cut from 80 to 68.

Elsewhere, FedEx (FDX) remains a point of contention among analysts. While Citigroup and B of A Securities issued modest target increases—moving the stock to 359 and 378 respectively—Stifel and UBS opted for substantial downward revisions, pulling their targets back to 326 and 350. This creates a wide variance in how the street views the logistics giant’s near-term trajectory.

Ticker Firm Dir Prior→Current
SHW Citigroup Up 355 → 380
CE Citigroup Down 80 → 68
FDX Stifel Down 442 → 326
BSX Jefferies Down 100 → 67

Reading the revisions

The contrast between the bullish upgrades in Materials and the aggressive downgrades elsewhere is striking. For instance, Jefferies issued a sharp reduction for Boston Scientific (BSX), dropping the target from 100 to 67, a move that starkly contrasts with the steady, incremental upgrades seen in the Financials sector. Within that group, Truist Securities pushed AXP to 375, while Piper Sandler nudged MET up to 90 (an 8.7% implied upside).

These revisions often serve as a reaction to underlying operational shifts rather than just macro sentiment. It is worth tracking these market moves to see if the downward pressure on firms like DOW and LYB—which now show implied upsides of 43.8% and 43.2% respectively—triggers a bottom-fishing response from the broader market. When a firm like Citigroup downgrades a name while simultaneously flagging a large implied upside, it suggests that while the target has been lowered, the valuation may still be viewed as disconnected from the current market price. Monitoring these gaps provides a clearer picture of where analysts are losing patience versus where they are simply recalibrating for volatility.

Read article →

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 1Insider Sells: 5

Whale Trades (C-Level Large Buys)

Major insider buying detected recently.

HEMSLEY STEPHEN J (Chief Executive Officer) - 86,700 shares

Recent Insider Transactions

DateNamePositionTransactionShares
8/21/2026CONWAY PATRICK HUGHOfficerSale at price 390.00 per share.1,169
8/5/2026CONWAY PATRICK HUGHOfficerSale at price 410.00 per share.500
4/23/2026CONWAY PATRICK HUGHOfficerSale at price 355.00 per share.800
9/11/2025BAKER CHARLES DDirectorSale at price 356.05 per share.27
6/10/2025CONWAY PATRICK HUGHChief Executive OfficerSale at price 305.00 per share.589
5/16/2025HEMSLEY STEPHEN JChief Executive OfficerPurchase at price 288.57 per share.86,700

Frequently Asked Questions

Q. What is the current target price and upside for UNH?

A. The current target price for UnitedHealth Group Incorporated is $481.72, which implies a 27.9% upside from the current price of $376.59. This is based on the consensus of 25 Wall Street analysts.

Q. What is the current analyst recommendation for UNH?

A. Currently, there are 7 Strong Buy, 15 Buy, 4 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying UNH stock recently?

A. Over the past 6 months, there have been 1 insider buys and 5 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Healthcare

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer →